Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...
(RTTNews) - Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (SWTUY.PK), Thursday said that the U.S. Food and Drug Administration or FDA has accepted its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback